Reports of a respiratory ... of unusual outbreak patterns. Schaffner explained that hMPV is a respiratory infection similar to the flu, COVID, and respiratory syncytial virus (RSV), but most ...

In a recent final analysis of a phase 3 trial, the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine maintained high efficacy and a favorable safety profile against RSV-associated ...

As temperatures drop, the flu and respiratory syncytial virus (RSV ... the timing of these illnesses is tied to weather and seasonal patterns. "It's unique every year; we see it hit at a different ...

Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared ...

Adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) have a 2.7-fold increased risk of death within a year compared to the general population.

Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting ...

A study reveals that Respiratory Syncytial Virus-associated Acute Respiratory Infection increases death risk in adults. The risk is three times higher within a year. RSV can lead to ...

Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in hospitalized infants under six months of age with respiratory syncytial virus.